DNMT3A and acute myeloid leukemia: Indeed, the authors showed that early intervention targeting chromatin regulators and therefore preventing the occurrence of full-blown AML, is possible in a Npm1/Dnmt3a mutant conditional knock-in mouse model, and suggested that similar preventative epigenetic approaches could become a future possibility also for humans at high risk of developing AML [113].